Sofinnova Partners
Sofinnova closes eighth fund on €300m
Biotech-focused vehicle will write €15-20m tickets to finance 15-20 deals in total
Sofinnova's Cerenis in €226m IPO
French biotech company raises €53.4m as part of listing
Sofinnova et al. invest $42m in Green Biologics
Company has also secured $34m in debt alongside capital increase
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round
Balderton and Sofinnova inject €4.5m into MyTomorrows
Online healthcare platform to invest in development and US expansion
VC-backed ProQR raises $97.5m in IPO
Listed Dutch biotech develops drugs designed for the treatment of genetic disorders
Richter joins Sofinnova from Novo Seeds
Former investment director joins after seven years in Denmark
VC-backed ProQR files for $75m IPO
Sofinnova is company's largest shareholder
Auris’ delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
Deal in focus: Capricorn et al. invest €36m in Avantium
Company attracted funding from VC backers as well as corporates
VC-backed Pixium floats with €100m market cap
Company sold 4.2 million shares at 828 euro cents apiece
Sofinnova et al. inject €36m into Avantium
Capital injection is from consortium of VCs and strategic trade players
VC-backed Pixium plans flotation
Company could raise up to €36.6m in IPO
Sofinnova Partners leads €16.5m series-A round for Lysogene
VC has been involved in company since seed funding stage
VC-backed Mainstay valued at €90m in IPO
Company raises €18m with flotation on French and Irish markets
Sofinnova Ventures leads $57m series-B for Nucana
Existing investors also join round
SEP’s Metaforic sold to VC-backed Inside Secure for $11.6m
Buyer backed by Sofinnova and Gimv
VC-backed Mainstay announces intention to float
Medical therapy developer to sell shares on Euronext Paris and Irish Stock Exchange
VC-backed McPhy raises €32m in IPO
Offer oversubscribed by 8.6x
EdRip, Sofinnova lead €18m round for Inotrem
Biomed Invest and Inserm Transfert Initiative also take part
VC-backed McPhy to float on Euronext
Company could raise up to €24.2m
Crescendo Biologics secures £17.5m series-A
UK biotech Crescendo Biologics has raised £17.5m in its series-A funding round from Imperial Innovations, Astellas Venture Management (AVM) and existing investor Sofinnova Partners.